D. Labrecque

发表

Hepatocellular carcinoma (HCC): a global perspective.

P. Malfertheiner, J. Bruix, M. Sherman, 2010, Journal of clinical gastroenterology.

Gallbladder Scalloping, Mammillated Caudate Lobe, and Inferior Vena Cava Scalloping: Three Novel Ultrasound Signs of Cirrhosis.

M. Abu-Yousef, D. Labrecque, M. Amarneh, 2018, Academic radiology.

GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation.

M. Gale, J. Stapleton, D. Labrecque, 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Four Generations of Arteriohepatic Dysplasia

G. F. Judisch, F. Mitros, D. Labrecque, 2007, Hepatology.

Mental and physical symptoms associated with lower social support for patients with hepatitis C.

S. Zickmund, R. Arnold, D. Labrecque, 2006, World journal of gastroenterology.

World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective.

P. Malfertheiner, J. Bruix, M. Sherman, 2010, Journal of gastrointestinal and liver diseases : JGLD.

Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C core protein.

B. Britigan, D. Labrecque, M. McCormick, 2004, The Journal of infectious diseases.

"They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C.

Evelyn Y. Ho, S. Zickmund, D. Labrecque, 2003, Journal of general internal medicine.

Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease.

M. Abu-Yousef, R. Gingrich, D. Labrecque, 1990, AJR. American journal of roentgenology.

Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests.

J. Stapleton, F. Mitros, D. Labrecque, 1997, The Journal of infectious diseases.

Risk factors for hepatitis C fibrosis: a prospective study of United States veterans * compared with nonveterans

J. Stapleton, D. Labrecque, J. Stapleton, 2007, Journal of viral hepatitis.

World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

S. Sarin, Z. Abbas, S. Hamid, 2014, Journal of clinical gastroenterology.

Loss of the CD5+ and CD45RAhi B cell subsets in alcoholics

T. Waldschmidt, D. Labrecque, R. Cook, 1996, Clinical and experimental immunology.

Hepatocellular Carcinoma in sub-saharan africa : The Immediate need is to Improve the Diagnosis and Treatment of the Tumor , and in the longer Term to Prevent the Tumor

S. Sarin, S. Hamid, F. Villamil, 2013 .

The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial)

K. Brown, S. Harrison, D. Labrecque, 2015, Therapeutic advances in gastroenterology.

Hepatitis C virus (HCV) infection and cryoglobulinemia: Analysis of whole blood and plasma HCV‐RNA concentrations and correlation with liver histology

J. Stapleton, P. Kirby, F. Mitros, 2000, Hepatology.

Detection of Hepatitis B Virus DNA Directly in Human Serum by a Simplified Molecular Hybridization Test: Comparison to HBeAg/ Anti‐HBe Status in HBsAg Carriers

D. Shafritz, M. Kew, D. Labrecque, 2007, Hepatology.

Recombinant hepatitis C virus‐like particles expressed by baculovirus: Utility in cell‐binding and antibody detection assays

J. Stapleton, D. Labrecque, S. L. George, 2002, Journal of medical virology.

The Role of Hepatotrophic Factors in Liver Regeneration — A Brief Review Including a Preliminary Report of the In Vitro Effects of Hepatic Regenerative Stimulator Substance (SS)

D. Labrecque, D. LaBrecque, 1979, The Yale journal of biology and medicine.

The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature.

D. Labrecque, B. Runyon, S. Anuras, 1980, The American journal of medicine.

TH1 cytokine response of CD57+ T-cell subsets in healthy controls and patients with alcoholic liver disease.

R. A. Coleman, T. Waldschmidt, Z. Ballas, 2001, Alcohol.

High-priority communication $ T H 1 cytokine response of CD57 + T-cell subsets in healthy controls and patients with alcoholic liver disease

R. A. Coleman, T. Waldschmidt, Z. Ballas, 2001 .

Frequency and characteristics of hyperbilirubinemia associated with bacteremia.

D. Labrecque, W. Hierholzer, T. Franson, 1985, Reviews of infectious diseases.

Changes in lysosomal cathepsins during liver regeneration.

D. Labrecque, G. Jones, H. Singh, 1980, Biochimica et biophysica acta.

Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy.

R. Wiesner, A. McCullough, A. Read, 1986, Annals of internal medicine.

Mitogenic effects of hepatic stimulator substance on cultured nonparenchymal liver epithelial cells

D. Shafritz, S. Gupta, D. Labrecque, 1992, Hepatology.

Serial bilirubin determinations as a prognostic marker in clinical infections.

R. Hoffmann, D. Labrecque, B. Buggy, 1989, The American journal of the medical sciences.

Successful treatment of hepatic venocclusive disease in a bone marrow transplant patient with side-to-side portacaval shunt.

J. Murray, R. Gingrich, K. Pringle, 1987, Gastroenterology.

Liver Ultrastructure in Mitochondrial Urea Cycle Enzyme Deficiencies and Comparison with Reye's Syndrome

P. Latham, D. Labrecque, J. Mcreynolds, 1984, Hepatology.

Older Donor Livers Show Early Severe Histological Activity, Fibrosis, and Graft Failure After Liver Transplantation for Hepatitis C

R. Kalil, P. Kirby, F. Mitros, 2007, Transplantation.

Hepatocyte growth factor--how do I know thee? Let me count the ways.

D. Labrecque, 1992, Gastroenterology.

Treatment of hepatitis C cryoglobulinemia: Mission and challenges

D. Labrecque, Z. Kayali, W. Schmidt, 2006, Current treatment options in gastroenterology.

Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells

J. Stapleton, D. Labrecque, D. Klinzman, 1998, Hepatology.

Direct detection of hepatitis C virus (HCV) RNA from whole blood, and comparison with HCV RNA in plasma and peripheral blood mononuclear cells

J. Stapleton, D. Labrecque, D. Klinzman, 1995, Journal of medical virology.

Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver.

D. Labrecque, L. Pesch, 1975, The Journal of physiology.

Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C

John B. Wong, Sanjeev Arora, Uwe Siebert, 2003 .

Purification and physical‐chemical characterization of hepatic stimulator substance

D. Labrecque, S. Fogerty, G. Steele, 1987, Hepatology.

Management of Ascites in Cirrhosis and Portal Hypertension

D. Labrecque, J. Ahluwalia, 2007 .

Chapter 26 – Drug-Induced Liver Injury

Dean P. Jones, H. Bonkovsky, S. Shedlofsky, 2006 .

WGO Guidance for the Care of Patients With COVID-19 and Liver Disease

B. McMahon, C. Yurdaydın, S. Hamid, 2020, Journal of clinical gastroenterology.

Diurnal rhythm: effects on hepatic regeneration and hepatic regenerative stimulator substance.

N. Bachur, D. Labrecque, A. Feigenbaum, 1978, Science.

Heritable urea cycle enzyme deficiency-liver disease in 16 patients.

C. Riely, P. Latham, D. Labrecque, 1979, The Journal of pediatrics.

Hepatic stimulator substance: physicochemical characteristics and specificity.

N. Bachur, D. Labrecque, 1982, The American journal of physiology.

Lymphoreticular malignancy presenting as fulminant hepatic disease

T. Colby, D. Labrecque, 1982 .

The risk of hepatitis B transmission from health care workers to patients in a hospital setting—A prospective study

R. Woolson, L. Lutwick, D. Labrecque, 1986, Hepatology.

Diseases of the liver and biliary tract

G. Gitnick, D. Labrecque, F. Moody, 1992 .

“They treated me like a leper”

Evelyn Y. Ho, S. Zickmund, D. Labrecque, 2003, Journal of General Internal Medicine.

SUPRAHEPATIC VENACAVAPLASTY (CAVAPLASTY) WITH RETROHEPATIC CAVA EXTENSION IN LIVER TRANSPLANTATION: EXPERIENCE WITH FIRST 115 CASES

F. Mitros, D. Labrecque, S. Rayhill, 2001, Transplantation.

Omeprazole heals mucosal ulcers associated with endoscopic injection sclerotherapy

D. Labrecque, G. Neil, F. Johlin, 1992, Digestive Diseases and Sciences.

Ocular findings in arteriohepatic dysplasia (Alagille's syndrome).

D. Labrecque, K. Romanchuk, G. Judisch, 1981, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

Characterization of Hepatitis G Virus (GB-C Virus) Particles: Evidence for a Nucleocapsid and Expression of Sequences Upstream of the E1 Protein

Jack T. Stapleton, R. Gish, J. McLinden, 1998, Journal of Virology.

World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013.

Sanjeev Arora, P. Malfertheiner, Z. Abbas, 2014, Journal of clinical gastroenterology.

Sulindac (Clinoril) hepatitis.

D. Labrecque, A. Dhand, Douglas R. LaBrecque, 1981, Gastroenterology.

Hepatitis C virus‐infected patients report communication problems with physicians

S. Zickmund, S. Hillis, M. Barnett, 2004, Hepatology.

Liver transplantation for disulfiram-induced fulminant hepatic failure.

T. Layden, F. Mitros, S. Mohanty, 2004, Journal of clinical gastroenterology.

Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis.

F. Mitros, D. Labrecque, J. Goeken, 1993, American journal of clinical pathology.

Ethanol and natural killer cells. I. Activity and immunophenotype in alcoholic humans.

Z. Ballas, D. Labrecque, D. Vandersteen, 1997, Alcoholism, clinical and experimental research.

Confusion for Fifteen Years: A Case of Abernethy Malformation.

D. Labrecque, J. Klair, K. Soota, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Modulation of T-cell adhesion markers, and the CD45R and CD57 antigens in human alcoholics.

T. Waldschmidt, Z. Ballas, D. Labrecque, 1995, Alcoholism, clinical and experimental research.

Recombinant Hepatitis A Virus Antigen: Improved Production and Utility in Diagnostic Immunoassays

S. Perlman, P. Winokur, J. Stapleton, 1998, Journal of Clinical Microbiology.

A Study of Inheritance in Progressive Intrahepatic Cholestasis: Hepatic excretory Function in Unaffected Family Members

C. Riely, D. Labrecque, Y. Hsia, 1979, Pediatric Research.

A father and son with cholestasis and peripheral pulmonic stenosis: a distinct form of intrahepatic cholestasis.

A. Horwich, C. Riely, D. Labrecque, 1978, The Journal of pediatrics.

Liver regeneration investigated in a non-human primate model (Macaca mulatta).

J. Blanchard, Huifeng Liu, N. Theise, 2002, Journal of hepatology.

Chapter 29 The Preparation and Characterization of Intact Isolated Parenchymal Cells from Rat Liver

D. Labrecque, R. B. Howard, 1976 .

Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load.

J. Stapleton, Jian-qiu Han, D. Labrecque, 1997, The Journal of infectious diseases.

Liver regeneration: a picture emerges from the puzzle.

D. Labrecque, D. LaBrecque, 1994, The American journal of gastroenterology.

Personality disorder as a contraindication for liver transplantation in alcoholic cirrhosis.

W. Yates, D. Labrecque, D. Pfab, 1998, Psychosomatics.

The evolving nature of "infantile obstructive cholangiopathy".

F. Ghishan, F. Mitros, D. Labrecque, 1980, The Journal of pediatrics.

A large biloma causing gastric outlet obstruction after a percutaneous liver biopsy.

D. Labrecque, J. Ahluwalia, 2004, Journal of clinical gastroenterology.

Ophthalmic features of Alagille syndrome (arteriohepatic dysplasia).

J. Pulido, D. Labrecque, K. Ossoinig, 1993, Journal of pediatric ophthalmology and strabismus.

Severe hepatic damage after acetaminophen use in psittacosis.

A. Davis, C. Helms, F. Mitros, 1983, The American journal of medicine.

Predicting cancer mortality: Developing a new cancer care variable using mixed methods and the quasi-statistical approach.

James E. Bost, Laura A. Shinkunas, Susan L. Zickmund, 2013, Health services research.

A model to examine the validity of the 6-month abstinence criterion for liver transplantation.

W. Yates, D. Labrecque, M. Voigt, 1998, Alcoholism, clinical and experimental research.

Corset liver.

D. Labrecque, S. Shirazi, D. Philips, 1985, Journal of clinical gastroenterology.

Majority of patients with hepatitis C express physical, mental, and social difficulties with antiviral treatment

S. Zickmund, R. Arnold, C. Bryce, 2006, European journal of gastroenterology & hepatology.

A commonsense approach to variceal bleeding.

D. Labrecque, 1997, Clinics in liver disease.

Prospective Comparison of Whole-Blood- and Plasma-Based Hepatitis C Virus RNA Detection Systems: Improved Detection Using Whole Blood as the Source of Viral RNA

R. Woolson, M. Pfaller, J. Stapleton, 1999, Journal of Clinical Microbiology.

T-cell activation after chronic ethanol ingestion in mice.

Xiaoyan Zhu, R. A. Coleman, T. Waldschmidt, 2004, Alcohol.

Lipogranulomas and Gold in the Liver in Rheumatoid Arthritis

S. Landas, D. Furst, F. Mitros, 1992, The American journal of surgical pathology.

Stimulation of HTC hepatoma cell growth in vitro by hepatic stimulator substance (HSS). Interactions with serum, insulin, glucagon, epidermal growth factor and platelet derived growth factor.

D. Labrecque, S. Fogerty, M. Wilson, 1984, Experimental cell research.

The risk of hepatitis B transmission from staff to patients in hemodialysis units–‐an overrated problem?

D. Labrecque, A. Dhand, 1981, Hepatology.

In vitro stimulation of cell growth by hepatic stimulator substance.

D. Labrecque, 1982, The American journal of physiology.

Lymphoreticular malignancy presenting as fulminant hepatic disease.

T. Colby, D. Labrecque, 1982, Gastroenterology.

A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C.

P. Kirby, A. Stolpen, D. Labrecque, 2006, Transplantation proceedings.

The reliability of alcoholism history in patients with alcohol-related cirrhosis.

W. Yates, D. Labrecque, D. Pfab, 1998, Alcohol and alcoholism.

Intrahepatic cholestasis after gold therapy in juvenile rheumatoid arthritis.

F. Ghishan, D. Labrecque, K. Younoszai, 1978, The Journal of pediatrics.

Effect of chronic ethanol ingestion on hepatic and intestinal acyl coenzyme A:Cholesterol acyltransferase and 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase in the rat

F. Field, D. Labrecque, Douglas R. Labrecque, 1985, Hepatology.

Studies on the biological characterization and mitogenic interactions between hepatic stimulator substance and acidic fibroblast growth factor.

M. Kan, W. Mckeehan, S. Gupta, 1994, Cancer letters.

Progressive multifocal leukoencephalopathy with peripheral demyelinating neuropathy in a liver transplant patient.

G. Testa, F. Mitros, S. Mohanty, 2007, Gastroenterology & hepatology.

Visualization and characterization of GB virus‐C particles: evidence for a nucleocapsid

D. Soll, K. Daniels, D. Labrecque, 1999, Journal of viral hepatitis.

The importance of the techniques employed during the enzymatic preparation of isolated liver parenchymal cells

N. Bachur, D. Labrecque, R. B. Howard, 1973, Journal of cellular physiology.